Skip to main content
Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: Role of Canagliflozin on function of CD34+ve endothelial progenitor cells (EPC) in patients with type 2 diabetes

Fig. 2

Migration Assay in response to SDF1alpha at 10 ng/ml concentration and gene expression of SDF1a receptor, CXCR-4 on CD34+ve cells. a Mean migration of CD34+ve cells towards SDF1-α (at 10 ng/ml) increased from visit 1 to 3 in Canagliflozin group as compared to placebo group (for visit 1 to 3 p = 0.03 and for visit 2–3 p = 0.05). b CXCR4 gene expression on CD34 positive cells is increased (p = 0.06) in Canagliflozin group as compared to placebo group at visit 3

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840